Phase I/II Trial of Temsirolimus and Perifosine for Recurrent or Progressive Malignant Gliomas
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 21 Jun 2017
At a glance
- Drugs Perifosine (Primary) ; Temsirolimus (Primary)
- Indications Anaplastic astrocytoma; Astrocytoma; Glioblastoma; Glioma; Oligodendroglioma
- Focus Adverse reactions; Therapeutic Use
- 05 Oct 2015 Planned primary completion date changed from 1 Oct 2015 to 1 Jul 2016as reported by ClinicalTrials.gov record.
- 17 May 2015 Planned primary completion date changed from 1 Jun 2015 to 1 Oct 2015 as reported by ClinicalTrials.gov
- 20 May 2014 Planned End Date changed from 1 Jun 2014 to 1 Jun 2015 as reported by ClinicalTrials.gov record.